SEIA
ENTX icon

Signature Estate & Investment Advisors’s Entera Bio ENTX Stock Holding History

Signature Estate & Investment Advisors’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.8K Hold
47,328
– – ﹤0.01% 663
2026
Q1 		$52.5K Hold
47,328
– – ﹤0.01% 643
2025
Q4 		$91.8K Hold
47,328
– – ﹤0.01% 600
2025
Q3 		$90.9K Hold
47,328
– – ﹤0.01% 592
2025
Q2 		$89.9K Hold
47,328
– – ﹤0.01% 569
2025
Q1 		$80.5K Hold
47,328
– – ﹤0.01% 543
2024
Q4 		$100K Hold
47,328
– – ﹤0.01% 530
2024
Q3 		$89.9K Buy
+47,328
New +$84K ﹤0.01% 517

Other funds holding ENTX

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Signature Estate & Investment Advisors's ENTX Position: Q2 2026 in Review

Signature Estate & Investment Advisors held its Entera Bio (ENTX) position steady in Q2 2026 at 47,328 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Signature Estate & Investment Advisors first reported a position in ENTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $100K in Q4 2024. 4 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Signature Estate & Investment Advisors held 47,328 shares of Entera Bio worth $83.8K as of Q2 2026.
  • Signature Estate & Investment Advisors left its Entera Bio share count unchanged in Q2 2026.
  • Entera Bio made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #663 holding.
  • Signature Estate & Investment Advisors first reported a position in Entera Bio in Q3 2024 and has held it in 8 quarters since.
  • Signature Estate & Investment Advisors's Entera Bio position peaked at $100K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.